Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Background: Approximately 50% of non-small cell lung cancer (NSCLC) patients with acquired resistance to EGFR-TKI harbor the EGFR mutation T790M. The recent development and wide use of third-generation EGFR-TKIs targeting T790M-mutant NSCLCs have increased the importance of rebiopsy after EGFR-TKI f...

Descripción completa

Detalles Bibliográficos
Autores principales: Goag, Eun Kyong, Lee, Jung Mo, Chung, Kyung Soo, Kim, Song Yee, Leem, Ah Young, Song, Joo Han, Jung, Ji Ye, Park, Moo Suk, Chang, Yoon Soo, Kim, Young Sam, Chang, Joon, Kim, Eun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868179/
https://www.ncbi.nlm.nih.gov/pubmed/29581791
http://dx.doi.org/10.7150/jca.21650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868179/
https://www.ncbi.nlm.nih.gov/pubmed/29581791
http://dx.doi.org/10.7150/jca.21650

Ejemplares similares